UNIVERSITY OF CALIFORNIA, IRVINE
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1965-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.uci.edu
Clinical Trials
443
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (313 trials with phase data)• Click on a phase to view related trials
Umbilical CB-NK Expressing sIL-15 & PD-L1 +/- Atezolizumab in NSCLC Pts Refractory to PD-1/PD-L1
- Conditions
- Non-small Cell Lung CancerNSCLCLung Cancer, Non-small CellLung Cancer
- Interventions
- Drug: NK-102
- First Posted Date
- 2025-07-08
- Last Posted Date
- 2025-07-10
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 9
- Registration Number
- NCT07053007
- Locations
- 🇺🇸
Chao Family Comprehensive Cancer Center University of California, Irvine, Orange, California, United States
Wearable Device and Behavioral Support for Enhancing Arm Use After Stroke
- Conditions
- Chronic Stroke Patients
- First Posted Date
- 2025-06-27
- Last Posted Date
- 2025-06-27
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 32
- Registration Number
- NCT07042152
- Locations
- 🇺🇸
University of California Irvine, Irvine, California, United States
Relaxation Music for Chronic Pain
- Conditions
- IBS - Irritable Bowel SyndromeIBD - Inflammatory Bowel Disease
- First Posted Date
- 2025-05-28
- Last Posted Date
- 2025-05-28
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 120
- Registration Number
- NCT06993272
- Locations
- 🇺🇸
University of California Irvine, Orange, California, United States
Health Questionnaire Study
- Conditions
- Anxiety Disorder (Panic Disorder or GAD)Depression - Major Depressive Disorder
- First Posted Date
- 2025-05-04
- Last Posted Date
- 2025-05-04
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 200
- Registration Number
- NCT06956378
- Locations
- 🇺🇸
University of California - Irvine, Orange, California, United States
Chatbot for Online Support Groups to Treat Tobacco Addiction
- Conditions
- Tobacco DependenceTobacco Use Disorder
- First Posted Date
- 2025-05-01
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 120
- Registration Number
- NCT06952725
- Prev
- 1
- 2
- 3
- 4
- 5
- 89
- Next
News
Engineered Microglia: A Revolutionary Approach to Treating Alzheimer's Disease
UC Irvine researchers have developed a groundbreaking therapy using CRISPR-edited microglia that can detect and target amyloid plaques in Alzheimer's disease, delivering therapeutic proteins precisely where needed.
INSPIRE Trials: Computerized Alerts Improve Antibiotic Selection in Hospitalized Patients by Up to 35%
• NIH-funded clinical trials involving over 316,000 patients across 92 hospitals demonstrate that computerized alerts can improve appropriate antibiotic selection by 35% for abdominal infections and 28% for skin and soft tissue infections. • The INSPIRE trials used patient-specific data to identify individuals at low risk for antibiotic-resistant infections, prompting physicians to switch from broad-spectrum to standard antibiotics when appropriate. • Researchers from UC Irvine, Harvard Pilgrim Health Care Institute, and HCA Healthcare collaborated on the studies, which could significantly reduce antibiotic resistance and improve patient outcomes nationwide.